Cargando…

Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study

BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zhiyong, Li, Zhilian, Dong, Wei, Chen, Yuanhan, Li, Ruizhao, Wu, Yanhua, Lin, Ting, Tao, Yiming, Liang, Huaban, Wang, Wenjian, Liu, Shuangxin, Ye, Zhiming, Shi, Wei, Liang, Xinling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101350/
https://www.ncbi.nlm.nih.gov/pubmed/32469090
http://dx.doi.org/10.1002/clc.23388
_version_ 1783688947492192256
author Xie, Zhiyong
Li, Zhilian
Dong, Wei
Chen, Yuanhan
Li, Ruizhao
Wu, Yanhua
Lin, Ting
Tao, Yiming
Liang, Huaban
Wang, Wenjian
Liu, Shuangxin
Ye, Zhiming
Shi, Wei
Liang, Xinling
author_facet Xie, Zhiyong
Li, Zhilian
Dong, Wei
Chen, Yuanhan
Li, Ruizhao
Wu, Yanhua
Lin, Ting
Tao, Yiming
Liang, Huaban
Wang, Wenjian
Liu, Shuangxin
Ye, Zhiming
Shi, Wei
Liang, Xinling
author_sort Xie, Zhiyong
collection PubMed
description BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher risk of cardiovascular comorbidity in PGD. METHODS: In a retrospective observational design, we analyzed 3622 hospitalized adult PGD patients and compared the prevalence of cardiovascular comorbidity in non‐MS, MS with and without DM. Risk factors for cardiovascular comorbidity were identified using univariate and multivariate logistic regression. RESULTS: Among 3622 PGD patients, 308 (8.5%) cases accompanied with MS, including 180 (5.0%) patients with DM and 128 (3.5%) without DM. One hundred and sixty four (4.5%) cases coexisted with cardiovascular comorbidity. Patients with MS and concomitant DM exhibited a higher prevalence of cardiovascular comorbidity than those without MS stratified by estimated glomerular filtration rate and pathological types. Logistic regression showed that MS and concomitant DM (OR: 2.496, 95% CI: 1.600‐3.894, P < .001), older age (OR: 1.060, 95% CI: 1.047‐1.074, P < .001), male (OR: 1.536, 95% CI: 1.072‐2.200, P = .019), higher level of serum ti (OR: 1.002, 95% CI: 1.001‐1.003, P < .001), hyperuricemia (OR: 1.901, 95% CI: 1.327‐2.725, P < .001), idiopathic membranous nephropathy (OR: 2.874, 95% CI: 1.244‐6.640, P < .001) and focal segmental glomerulosclerosis (OR: 2.906, 95% CI: 1.147‐7.358, P < .001) were independently associated with a higher risk for cardiovascular comorbidity. CONCLUSIONS: In PGD patients, MS and concomitant DM are associated with an increased risk for cardiovascular comorbidity. More evidence for the causal link between MS/DM and cardiovascular outcomes is needed to be clarified.
format Online
Article
Text
id pubmed-8101350
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-81013502021-05-10 Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study Xie, Zhiyong Li, Zhilian Dong, Wei Chen, Yuanhan Li, Ruizhao Wu, Yanhua Lin, Ting Tao, Yiming Liang, Huaban Wang, Wenjian Liu, Shuangxin Ye, Zhiming Shi, Wei Liang, Xinling Clin Cardiol Clinical Investigations BACKGROUND: Metabolic syndrome (MS) and diabetes mellitus (DM) are risk factors for cardiovascular diseases in general population. However, there was a paucity of studies investigating their impact in primary glomerular diseases (PGD). HYPOTHESIS: MS and concomitant DM are associated with higher risk of cardiovascular comorbidity in PGD. METHODS: In a retrospective observational design, we analyzed 3622 hospitalized adult PGD patients and compared the prevalence of cardiovascular comorbidity in non‐MS, MS with and without DM. Risk factors for cardiovascular comorbidity were identified using univariate and multivariate logistic regression. RESULTS: Among 3622 PGD patients, 308 (8.5%) cases accompanied with MS, including 180 (5.0%) patients with DM and 128 (3.5%) without DM. One hundred and sixty four (4.5%) cases coexisted with cardiovascular comorbidity. Patients with MS and concomitant DM exhibited a higher prevalence of cardiovascular comorbidity than those without MS stratified by estimated glomerular filtration rate and pathological types. Logistic regression showed that MS and concomitant DM (OR: 2.496, 95% CI: 1.600‐3.894, P < .001), older age (OR: 1.060, 95% CI: 1.047‐1.074, P < .001), male (OR: 1.536, 95% CI: 1.072‐2.200, P = .019), higher level of serum ti (OR: 1.002, 95% CI: 1.001‐1.003, P < .001), hyperuricemia (OR: 1.901, 95% CI: 1.327‐2.725, P < .001), idiopathic membranous nephropathy (OR: 2.874, 95% CI: 1.244‐6.640, P < .001) and focal segmental glomerulosclerosis (OR: 2.906, 95% CI: 1.147‐7.358, P < .001) were independently associated with a higher risk for cardiovascular comorbidity. CONCLUSIONS: In PGD patients, MS and concomitant DM are associated with an increased risk for cardiovascular comorbidity. More evidence for the causal link between MS/DM and cardiovascular outcomes is needed to be clarified. Wiley Periodicals, Inc. 2020-05-29 /pmc/articles/PMC8101350/ /pubmed/32469090 http://dx.doi.org/10.1002/clc.23388 Text en © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Xie, Zhiyong
Li, Zhilian
Dong, Wei
Chen, Yuanhan
Li, Ruizhao
Wu, Yanhua
Lin, Ting
Tao, Yiming
Liang, Huaban
Wang, Wenjian
Liu, Shuangxin
Ye, Zhiming
Shi, Wei
Liang, Xinling
Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title_full Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title_fullStr Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title_full_unstemmed Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title_short Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study
title_sort metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: a retrospective observational study
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101350/
https://www.ncbi.nlm.nih.gov/pubmed/32469090
http://dx.doi.org/10.1002/clc.23388
work_keys_str_mv AT xiezhiyong metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT lizhilian metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT dongwei metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT chenyuanhan metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT liruizhao metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT wuyanhua metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT linting metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT taoyiming metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT lianghuaban metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT wangwenjian metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT liushuangxin metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT yezhiming metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT shiwei metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy
AT liangxinling metabolicsyndromeandconcomitantdiabetesmellitusareassociatedwithhigherriskofcardiovascularcomorbidityinpatientswithprimaryglomerulardiseasesaretrospectiveobservationalstudy